Alcohol Use, Unspecified: Clinical Trials

1 trial for Alcohol Use, Unspecified, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Alcohol Use, Unspecified: new trials by email Literature Review of Alcohol Use, Unspecified trials Research Report on Alcohol Use, Unspecified

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin
Low-dose naltrexone, Gabapentin, Placebo - Chronic Pain, Alcohol Use, Unspecified
Phase 2CompletedBoston Medical Center452021-01-252022-11-10

Narrower conditions

Alcohol Drinking (1)  ·  Chronic Pain (1)  ·  HIV Infections (1)  ·  Inflammation (1)  ·  Pain (1)

Broader conditions

Behavior (1)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Drinking Behavior (1)  ·  Genital Diseases (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)

Interventions

Gabapentin (1)  ·  Naltrexone (1)

Sponsors

Boston Medical Center (1)

Countries

Russia (1)

Top investigators

Jeffrey H. Samet, MD, MA, MPH (1)

Results publications

PMID 38408060

NIH funding

UH3AA026193 (1)